CTTC 2026 Day 2 Opening Keynote
On Day 2 of the Clinical Trials Technology Congress 2026, the opening keynote explored how technology, real-time data and AI are transforming clinical development; enabling organisations to deliver smarter, more efficient clinical trials at scale. Moderator & Speakers Nicholas Lakin, Executive Managing Director, Syneos Health Consulting Astrid Scherer, Head of Product Development and Process Excellence Clinical Development (VP), Bayer Pharmaceuticals Rebecca Jackson, Associate Director, Global Development Systems, Johnson & Johnson Raja Shankar, Vice President, Machine Learning, AI & Technology Solutions, IQVIA To watch the talks and discussion please register below.
